Funded Grants
Children’s Hospital Boston
Investigator: Edward R. Smith
Urinary Biomarkers for Non-invasive Assessment of Therapeutic Efficacy in Glioma
Emory University School of Medicine
Investigator: Erwin G. Van Meir
Development of Protein Arrays for the Detection of Biomarkers in the CSF of Brain Tumor Patients
Johns Hopkins University
Investigator: Jaishri O. Blakeley
Amide Proton Transfer MR Imaging to Assess Tumor Response in Patients with Gliomas
Johns Hopkins University
Investigator: Luis A. Diaz
Circulating Tumor DNA as a Dynamic Biomarker in Malignant Gliomas
Johns Hopkins University
Investigator: Alena Hoská
Non-invasive Assessment of Glutamate in Glioblastoma Multiforme: Effect of Treatment
Massachusetts General Hospital
Investigator: Bob S. Carter
Exosome Analysis: A Non-Invasive Approach to Monitor Treatment Responses in Glioma Patients
Memorial Sloan-Kettering Cancer Center
Investigator: Andrew B. Lassman
Molecular Determinants of [18F]FACBC-PET Imaging in Brain Tumors
University of California (David Geffen School of Medicine at UCLA)
Investigator: Whitney B. Pope
Combining Genomics with Physiologic Imaging Biomarkers to Predict and Follow Treatment Response in Glioma
University of Texas MD Anderson Cancer Center
Investigator: Kenneth D. Aldape
A combined molecular and clinical predictor of progression vs. pseudoprogression in newly diagnosed GBM.
University of Washington
Investigator: Kristin R. Swanson
Patient-specific Metrics of Treatment Response
Vanderbilt University Medical Center
Investigator: Kyle D. Weaver
Monitoring Response to Therapy in Malignant Glioma Patients Using Blood-Based Epigenomic and Proteomic Biomarkers
|
